ScholarIQanswers from OpenAlex

Natural killer cells: a promising immunotherapy for cancer

PaperCitations, authors & open-access status

Natural killer cells: a promising immunotherapy for cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Natural killer cells: a promising immunotherapy for cancer have?

ScholarIQcitation count

Natural killer cells: a promising immunotherapy for cancer has 179 citations in the OpenAlex counts ScholarIQ stores.

When was Natural killer cells: a promising immunotherapy for cancer published?

ScholarIQyear

Natural killer cells: a promising immunotherapy for cancer has 2022 year in the ScholarIQ index.

What is the open-access status of Natural killer cells: a promising immunotherapy for cancer?

ScholarIQoa status

Natural killer cells: a promising immunotherapy for cancer has gold oa status in the ScholarIQ index.

What is the DOI of Natural killer cells: a promising immunotherapy for cancer?

ScholarIQdoi

The DOI for Natural killer cells: a promising immunotherapy for cancer is on the source record.

What is the PMID of Natural killer cells: a promising immunotherapy for cancer?

ScholarIQpmid

The PMID for Natural killer cells: a promising immunotherapy for cancer is on the source record.

What is the OpenAlex record for Natural killer cells: a promising immunotherapy for cancer?

ScholarIQopenalex

The OpenAlex for Natural killer cells: a promising immunotherapy for cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial